Latest Breaking News On - Company the common stock - Page 7 : comparemela.com

Form 8-K EyePoint Pharmaceuticals For: Jun 20

Form 8-K EyePoint Pharmaceuticals For: Jun 20
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWendyf diciccoKaren zaderejGeorgeo elstonAnthonyp adamisJohnb landisDavidr guyerDeloitte toucheSecurities exchangeExchange commission onCompany the common stockEyepoint pharmaceuticals incCompany board of directors theCommission file numberSecurities exchange actPoint pharmaceuticals

CARISMA THERAPEUTICS : AMENDED AND RESTATED 2014 STOCK INCENTIVE PLAN - Form 8-K

CARISMA THERAPEUTICS INC. AMENDED AND RESTATED 2014 STOCK INCENTIVE PLAN 1. Purpose . | June 9, 2023

United statesCommon stock of the companyCompany the common stockTherapeutics incCommittee of the boardSeahawk merger sub incCorporation law of the state delawareSesen bio incCompany the board onSecurities exchangeIncentive planCarisma therapeuticsSesen bioInternal revenue codeSecurities actRestricted stock

Form S-8 POS Broadmark Realty Capital

Form S-8 POS Broadmark Realty Capital
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

State of new yorkNew yorkUnited statesCity of new yorkMichaelj kesslerDavide brownThomase capasseExchange commissionCompany the common stockReady capital corporationExchange commission onMerger subBroadmark realty capital incAlston birdWall streetPrincipal executive offices

GreenLight Biosciences Enters into Definitive Merger

LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced.

United statesIngrid fungClay mitchellEric obrienThomas cramptonGreenlight biosciences holdingsFoley hoagCompany onCorporate affairsNasdaq stock exchangePromissory notes the private companySecurities exchangeCompany board of directorsBoard of directors the special committeeFall line investor relations departmentGoodwin procter

GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction

LEXINGTON, Mass., May 30, 2023 GreenLight Biosciences Holdings, PBC today announced that the Company has entered into a definitive agreement to be acquired by a group of buyers led by Fall. | May 30, 2023

United statesClay mitchellIngrid fungThomas cramptonEric obrienGoodwin procterFall line investor relations departmentCompany the common stockCompany common stockFall line capitalWhile the companyCompany investor relations department at copiesExchange commissionRoth capital partnersOmelveny myersCorporate affairs